BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23298964)

  • 21. [Rheumatoid arthritis: a cardiovascular disease?].
    Daïen CI; Fesler P
    Ann Cardiol Angeiol (Paris); 2012 Apr; 61(2):111-7. PubMed ID: 21885031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chronic inflammation increases the risk of cardiovascular disease in patients with rheumatoid arthritis].
    Troelsen LN; Jacobsen S
    Ugeskr Laeger; 2006 Sep; 168(39):3304-8. PubMed ID: 17032593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can treatment of chronic inflammatory diseases reduce the risk of diabetes mellitus?
    Bongartz T; Kudva Y
    JAMA; 2011 Jun; 305(24):2573-4. PubMed ID: 21693749
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases.
    Taylor PC
    Curr Opin Pharmacol; 2010 Jun; 10(3):308-15. PubMed ID: 20172761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better.
    Peters MJ; Voskuyl AE; Sattar N; Dijkmans BA; Smulders YM; Nurmohamed MT
    Int J Clin Pract; 2010 Sep; 64(10):1440-3. PubMed ID: 20716150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
    Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. News on the genetics of lipoprotein metabolism and cardiovascular disease.
    van de Sluis B; Kuivenhoven JA
    Curr Opin Lipidol; 2013 Apr; 24(2):185-6. PubMed ID: 23481232
    [No Abstract]   [Full Text] [Related]  

  • 28. Pulmonary manifestations of rheumatoid arthritis.
    Antin-Ozerkis D; Evans J; Rubinowitz A; Homer RJ; Matthay RA
    Clin Chest Med; 2010 Sep; 31(3):451-78. PubMed ID: 20692539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Insulin resistance and rheumatoid arthritis].
    Ferraz Amaro I; Díaz González F; González Juanatey C; González Gay MA
    Reumatol Clin; 2011; 7(2):124-9. PubMed ID: 21794795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of cardiovascular diseases in rheumatoid arthritis].
    Novikova DS; Popkova TV; Nasonov EL
    Ter Arkh; 2009; 81(5):88-96. PubMed ID: 19537595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiovascular diseases in rheumatoid arthritis].
    Rovenský J; Vlcek M; Imrich R
    Vnitr Lek; 2010 Jul; 56(7):721-3. PubMed ID: 20842919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis.
    Lee CK; Park JY; Shim JJ; Jang JY
    Endoscopy; 2011; 43 Suppl 2 UCTN():E326-7. PubMed ID: 22020709
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk of cardiovascular events and effect on mortality in patients with rheumatoid arthritis.
    Nossent H
    J Rheumatol; 2000 Sep; 27(9):2282-3. PubMed ID: 10990252
    [No Abstract]   [Full Text] [Related]  

  • 34. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
    Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A
    Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.
    van Eijk IC; de Vries MK; Levels JH; Peters MJ; Huizer EE; Dijkmans BA; van der Horst-Bruinsma IE; Hazenberg BP; van de Stadt RJ; Wolbink GJ; Nurmohamed MT
    Arthritis Rheum; 2009 May; 60(5):1324-30. PubMed ID: 19404933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal Salmonella enteritidis septicaemia in a rheumatoid arthritis patient treated with a TNF-alpha antagonist.
    Rijkeboer A; Voskuyl A; Van Agtmael M
    Scand J Infect Dis; 2007; 39(1):80-3. PubMed ID: 17366020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
    Baslund B; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
    Davis JM; Maradit-Kremers H; Gabriel SE
    J Rheumatol; 2005 Oct; 32(10):1856-62. PubMed ID: 16206334
    [No Abstract]   [Full Text] [Related]  

  • 39. Does cardiovascular risk factor profile influence prescribing of non-steroidal anti-inflammatory drugs in a rheumatoid population?
    Armstrong DJ; Quinn AD; McCausland EM; Wright GD; Finch MB
    Rheumatology (Oxford); 2007 Jul; 46(7):1209-10. PubMed ID: 17522094
    [No Abstract]   [Full Text] [Related]  

  • 40. [Disorders of calcium and phosphorus metabolism in rheumatoid arthritis].
    Ota K; Uezu A
    Nihon Rinsho; 1982; 40(12):2729-37. PubMed ID: 6761466
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.